Phase I/II trial of oncolytic reovirus (Reolysin) in combination with carboplatin/paclitaxel in patients (pts) with advanced solid cancers

被引：0
|
作者：
Karapanagiotou, E. [1 ,2 ,3 ,4 ]
Pandha, H. S. [1 ,2 ,3 ,4 ]
Hall, G. [1 ,2 ,3 ,4 ]
Chester, J. [1 ,2 ,3 ,4 ]
Melcher, A. [1 ,2 ,3 ,4 ]
Coffey, M. [1 ,2 ,3 ,4 ]
de Bono, J. [1 ,2 ,3 ,4 ]
Gore, M. E. [1 ,2 ,3 ,4 ]
Nutting, C. M. [1 ,2 ,3 ,4 ]
Harrington, K. J. [1 ,2 ,3 ,4 ]
机构：
[1] Royal Marsden Hosp, NHS Fdn Trust, London SW3 6JJ, England
[2] Univ Surrey, Guildford GU2 5XH, Surrey, England
[3] Leeds Inst Mol Med, Leeds, W Yorkshire, England
[4] Oncolyt Biotech Inc, Calgary, AB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14519
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A clinical phase I trial of topotecan in combination with carboplatin in patients with advanced solid tumors
    Thodtmann, R
    Kemmerich, M
    Depenbrock, H
    Heuser, A
    van Oosterom, AT
    Hanauske, AR
    ANNALS OF ONCOLOGY, 1998, 9 : 69 - 69
  • [32] Phase II study of carboplatin and paclitaxel in patients with advanced upper gastrointestinal cancers
    Philip, PA
    Gadgeel, S
    Hussain, M
    Zalupski, MM
    Shields, AF
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 141 - 141
  • [33] Phase I study of elisidepsin (E) in combination with carboplatin (C) in patients (pts) with advanced solid tumors
    Faivre, S. J.
    Ropert, S.
    Coronado, C.
    Alcantara, J.
    De Miguel, B.
    Soto, A.
    Szyldergemajn, S. A.
    Loussilaho, G.
    Mir, O.
    Goldwasser, F.
    Raymond, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [34] Phase I study of PM00104 in combination with carboplatin in patients (pts) with advanced solid tumors
    Calvo, Emiliano
    Gil, Marta
    Coronado, Cinthya
    Valer, Anna
    Duran, Ignacio
    Hidalgo, Manuel
    Pardo, Beatriz
    Calles, Antonio
    Garcia, Margarita
    Morelli, Pia
    Kahatt, Carmen
    Prados, Raquel
    Fernandez, Carlos
    Salazar, Ramon
    CANCER RESEARCH, 2012, 72
  • [35] Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results
    Elisabeth I. Heath
    George R. Blumenschein
    Roger B. Cohen
    Patricia M. LoRusso
    Noelle K. LoConte
    Sindy T. Kim
    Ana Ruiz-Garcia
    Richard C. Chao
    George Wilding
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 703 - 712
  • [36] Sunitinib in combination with paclitaxel and carboplatin in patients with advanced solid tumors: Updated phase I study results
    Heath, E. I.
    Blumenschein, G. R., Jr.
    Cohen, R. B.
    LoRusso, P. M.
    LoConte, N.
    Kim, S. T.
    Chao, R.
    Wilding, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [37] Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results
    Heath, Elisabeth I.
    Blumenschein, George R., Jr.
    Cohen, Roger B.
    LoRusso, Patricia M.
    LoConte, Noelle K.
    Kim, Sindy T.
    Ruiz-Garcia, Ana
    Chao, Richard C.
    Wilding, George
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 703 - 712
  • [38] Phase I/II study everolimus in combination with paclitaxel-carboplatin in patients with advanced adenocarcinoma of the stomach
    Loong, H. H.
    Mo, F.
    Li, L.
    Lee, C.
    Lam, K-C.
    Koh, J.
    Chiu, P.
    Teoh, A.
    Chan, A. T. C.
    Ng, E.
    Yeo, W.
    ANNALS OF ONCOLOGY, 2017, 28
  • [39] A phase I study of the combination of intravenous Reolysin (REO) and gemcitabine (GEM) in patients (pts) with advanced cancer
    Arkenau, H.
    Evans, J.
    Lokelma, M.
    Roxburgh, P.
    Morisson, R.
    Coffey, M.
    Gill, G.
    Mettinger, K.
    Thompson, B.
    de Bono, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [40] Phase I study of PM00104 in combination with carboplatin (C) in patients (pts) with advanced solid tumors
    Calvo, E.
    Gil, M.
    Coronado, C.
    Valer, A.
    Duran, I.
    Hidalgo, M.
    Pardo, B.
    Calles, A.
    Garcia, M.
    Morelli, P.
    Kahatt, C. M.
    Prados, R.
    Fernandez, C.
    Salazar, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345